142 related articles for article (PubMed ID: 32860240)
1. Crouzon syndrome with acanthosis nigricans and prominent diffuse hyperpigmentation associated with gain-of-function A391E mutation in FGFR3 gene.
Kariya H; Nakano H; Ishii N; Kaimi Y; Imai K; Nakanishi Y; Kunihiro N; Fukai K
J Dermatol; 2020 Dec; 47(12):e451-e452. PubMed ID: 32860240
[No Abstract] [Full Text] [Related]
2. [Acanthosis nigricans in children and Crouzon syndrome].
Lagaude M; Barreau M; Jokic M; Gerard M; DiRocco F; Hadj-Rabia S; Dompmartin A; Verneuil L
Ann Dermatol Venereol; 2014 Nov; 141(11):685-8. PubMed ID: 25442473
[TBL] [Abstract][Full Text] [Related]
3. Crouzon with Acanthosis Nigricans and Odontogenic Tumors: A Rare Form of Syndromic Craniosynostosis.
Xu W; McDonald-McGinn DM; Melchiorre AJ; Zackai EH; Bartlett SP; Taylor JA
Cleft Palate Craniofac J; 2018 Feb; 55(2):296-300. PubMed ID: 29351036
[TBL] [Abstract][Full Text] [Related]
4. Crouzon with acanthosis nigricans. Further delineation of the syndrome.
Arnaud-López L; Fragoso R; Mantilla-Capacho J; Barros-Núñez P
Clin Genet; 2007 Nov; 72(5):405-10. PubMed ID: 17935505
[TBL] [Abstract][Full Text] [Related]
5. Multiple consequences of a single amino acid pathogenic RTK mutation: the A391E mutation in FGFR3.
Chen F; Sarabipour S; Hristova K
PLoS One; 2013; 8(2):e56521. PubMed ID: 23437153
[TBL] [Abstract][Full Text] [Related]
6. Crouzon syndrome with acanthosis nigricans: a case-based update.
Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
[TBL] [Abstract][Full Text] [Related]
7. Crouzon syndrome with acanthosis nigricans: case report and mutational analysis.
Nagase T; Nagase M; Hirose S; Ohmori K
Cleft Palate Craniofac J; 2000 Jan; 37(1):78-82. PubMed ID: 10670894
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans.
Meyers GA; Orlow SJ; Munro IR; Przylepa KA; Jabs EW
Nat Genet; 1995 Dec; 11(4):462-4. PubMed ID: 7493034
[TBL] [Abstract][Full Text] [Related]
9. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
10. A recurrent mutation, ala391glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans.
Wilkes D; Rutland P; Pulleyn LJ; Reardon W; Moss C; Ellis JP; Winter RM; Malcolm S
J Med Genet; 1996 Sep; 33(9):744-8. PubMed ID: 8880573
[TBL] [Abstract][Full Text] [Related]
11. An association of acanthosis nigricans and Crouzon syndrome.
Koizumi H; Tomoyori T; Sato KC; Ohkawara A
J Dermatol; 1992 Feb; 19(2):122-6. PubMed ID: 1377724
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
Mir A; Wu T; Orlow SJ
JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
[TBL] [Abstract][Full Text] [Related]
13. Subtle radiographic findings of achondroplasia in patients with Crouzon syndrome with acanthosis nigricans due to an Ala391Glu substitution in FGFR3.
Schweitzer DN; Graham JM; Lachman RS; Jabs EW; Okajima K; Przylepa KA; Shanske A; Chen K; Neidich JA; Wilcox WR
Am J Med Genet; 2001 Jan; 98(1):75-91. PubMed ID: 11426459
[TBL] [Abstract][Full Text] [Related]
14. Expanding the phenotype for the recurrent p.Ala391Glu variant in FGFR3: Beyond crouzon syndrome and acanthosis nigricans.
Rymer K; Shiang R; Hsiung A; Pandya A; Bigdeli T; Webb BT; Rhodes J
Mol Genet Genomic Med; 2019 Jun; 7(6):e656. PubMed ID: 31016899
[TBL] [Abstract][Full Text] [Related]
15. Clinical signs, interventions, and treatment course of three different treatment protocols in patients with Crouzon syndrome with acanthosis nigricans.
de Planque CA; Wall SA; Dalton L; Paternoster G; Arnaud É; van Veelen MC; Versnel SL; Johnson D; Jayamohan J; Mathijssen IMJ
J Neurosurg Pediatr; 2021 Aug; 28(4):425-431. PubMed ID: 34388723
[TBL] [Abstract][Full Text] [Related]
16. Familial acanthosis nigricans due to K650T FGFR3 mutation.
Berk DR; Spector EB; Bayliss SJ
Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
[TBL] [Abstract][Full Text] [Related]
17. FGFR3 overactivation in the brain is responsible for memory impairments in Crouzon syndrome mouse model.
Cornille M; Moriceau S; Khonsari RH; Heuzé Y; Loisay L; Boitez V; Morice A; Arnaud E; Collet C; Bensidhoum M; Kaci N; Boddaert N; Paternoster G; Rauschendorfer T; Werner S; Mansour SL; Di Rocco F; Oury F; Legeai-Mallet L
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35254402
[TBL] [Abstract][Full Text] [Related]
18. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
[TBL] [Abstract][Full Text] [Related]
19. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
Vajo Z; Francomano CA; Wilkin DJ
Endocr Rev; 2000 Feb; 21(1):23-39. PubMed ID: 10696568
[TBL] [Abstract][Full Text] [Related]
20. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
